These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1580 related items for PubMed ID: 16123915

  • 1. Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention.
    Huisman MV, Bounameaux H.
    Semin Vasc Med; 2005 Aug; 5(3):276-84. PubMed ID: 16123915
    [Abstract] [Full Text] [Related]

  • 2. The role of ximelagatran in the treatment of venous thromboembolism.
    Schulman S.
    Pathophysiol Haemost Thromb; 2005 Aug; 34 Suppl 1():18-24. PubMed ID: 15812200
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ximelagatran.
    Choudhury A, Goyal D, Lip GY.
    Drugs Today (Barc); 2006 Jan; 42(1):3-19. PubMed ID: 16511607
    [Abstract] [Full Text] [Related]

  • 8. Treatment of venous thromboembolism and long-term prevention of recurrence: present treatment options and ximelagatran.
    Eriksson H.
    Drugs; 2004 Jan; 64 Suppl 1():37-46. PubMed ID: 15586626
    [Abstract] [Full Text] [Related]

  • 9. Pentasaccharides for the prevention of venous thromboembolism.
    Dong K, Song Y, Li X, Ding J, Gao Z, Lu D, Zhu Y.
    Cochrane Database Syst Rev; 2016 Oct 31; 10(10):CD005134. PubMed ID: 27797404
    [Abstract] [Full Text] [Related]

  • 10. Treatment of venous thromboembolism with the oral thrombin inhibitor, ximelagatran.
    Harenberg J, Ingrid J, Tivadar F.
    Isr Med Assoc J; 2002 Nov 31; 4(11):1003-5. PubMed ID: 12489490
    [Abstract] [Full Text] [Related]

  • 11. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
    Kahale LA, Hakoum MB, Tsolakian IG, Matar CF, Terrenato I, Sperati F, Barba M, Yosuico VE, Schünemann H, Akl EA.
    Cochrane Database Syst Rev; 2018 Jun 19; 6(6):CD006650. PubMed ID: 29920657
    [Abstract] [Full Text] [Related]

  • 12. Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatran.
    Eriksson H, Lundström T, Wåhlander K, Clason SB, Schulman S, THRIVE III Investigators.
    Thromb Haemost; 2005 Sep 19; 94(3):522-7. PubMed ID: 16268466
    [Abstract] [Full Text] [Related]

  • 13. Ximelagatran: a new oral anticoagulant.
    Hrebickova L, Nawarskas JJ, Anderson JR.
    Heart Dis; 2003 Sep 19; 5(6):397-408. PubMed ID: 14633322
    [Abstract] [Full Text] [Related]

  • 14. Clinical experience with ximelagatran in orthopaedic surgery.
    Eriksson B.
    Drugs; 2004 Sep 19; 64 Suppl 1():27-35. PubMed ID: 15586625
    [Abstract] [Full Text] [Related]

  • 15. Emerging options in the treatment of venous thromboembolism.
    Nutescu EA.
    Am J Health Syst Pharm; 2004 Dec 01; 61(23 Suppl 7):S12-7. PubMed ID: 15597574
    [Abstract] [Full Text] [Related]

  • 16. Ximelagatran: an orally active direct thrombin inhibitor.
    Gulseth MP.
    Am J Health Syst Pharm; 2005 Jul 15; 62(14):1451-67. PubMed ID: 15998925
    [Abstract] [Full Text] [Related]

  • 17. New anticoagulants for treatment of venous thromboembolism.
    Weitz JI.
    Circulation; 2004 Aug 31; 110(9 Suppl 1):I19-26. PubMed ID: 15339877
    [Abstract] [Full Text] [Related]

  • 18. Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial.
    Francis CW, Davidson BL, Berkowitz SD, Lotke PA, Ginsberg JS, Lieberman JR, Webster AK, Whipple JP, Peters GR, Colwell CW.
    Ann Intern Med; 2002 Oct 15; 137(8):648-55. PubMed ID: 12379064
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ximelagatran: direct thrombin inhibitor.
    Ho SJ, Brighton TA.
    Vasc Health Risk Manag; 2006 Oct 15; 2(1):49-58. PubMed ID: 17319469
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 79.